Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Apr 21;5(3):64-67.
doi: 10.1002/cld.446. eCollection 2015 Mar.

Prevention of hepatic encephalopathy recurrence

Barjesh Chander Sharma  1 , Sudhir Maharshi  1
Affiliations
Review

Prevention of hepatic encephalopathy recurrence

Barjesh Chander Sharma et al. Clin Liver Dis (Hoboken). .
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Probability of developing hepatic encephalopathy (HE) in patients receiving lactulose (dotted line) or placebo (continuous line). Figures in parentheses indicate the cumulative number of subjects who developed HE. Copyright 2009, Gastroenterology.1
Figure 2
Figure 2
Probability of developing hepatic encephalopathy in patients receiving lactulose (Gp‐L), probiotic treatment (Gp‐P), or no therapy (Gp‐N). Copyright 2012, Am J Gastoenterol.3
See this image and copyright information in PMC

References

    1. Sharma BC, Sharma P, Agrawal A, Sarin SK. Secondary prophylaxis of hepatic encephalopathy: an open‐label randomized controlled trial of lactulose versus placebo. Gastroenterology 2009;137:885‐891. - PubMed
    1. Bass NM, Mullen KD, Sanyal A, Poordad F, Neff G, Leevy CB, et al. Rifaximin treatment in hepatic encephalopathy. N Engl J Med 2010;362;1071‐1081. - PubMed
    1. Agrawal A, Sharma BC, Sharma P, Sarin SK. Secondary prophylaxis of hepatic encephalopathy in cirrhosis: an open‐label, randomized controlled trial of lactulose, probiotics, and no therapy. Am J Gastroenterol 2012;107:1043‐1050. - PubMed
    1. Rockey DC, Vierling JM, Mantry P, Ghabril M, Brown RS, Alexeeva O, et al. Randomized, double‐blind, controlled study of glycerol, phenylbutyrate in hepatic encephalopathy. Hepatology 2014;59:1073‐1083. - PMC - PubMed
    1. Les L, Doval E, Martinez RG, Planas M, Cárdenas G, Gómez P, et al. Effects of branched‐chain amino acids supplementation in patients with cirrhosis and a previous episode of hepatic encephalopathy: a randomized study. Am J Gastroenterol 2011;106:1081‐1088. - PubMed